Finance

Lists
ANTHEM:NSE
Anthem Biosciences Limited
₹858.50
-0.01%
(-0.100) 1D
Oct 1, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ANTHEM...
Open
₹851.50
High
₹859.75
Low
₹830.60
Mkt. cap
481.95B
Avg. vol.
887.72K
Volume
648.83K
Dividend
0.23%
Quarterly dividend
₹0.50
Ex-dividend date
Jun 25, 2026
P/E ratio
84.37
52-wk high
₹977.55
52-wk low
₹579.15
EPS
₹10.18
No. of employees
2K
Open
₹851.50
High
₹859.75
Low
₹830.60
Mkt. cap
481.95B
Avg. vol.
887.72K
Volume
648.83K
Dividend
0.23%
Quarterly dividend
₹0.50
Ex-dividend date
Jun 25, 2026
P/E ratio
84.37
52-wk high
₹977.55
52-wk low
₹579.15
EPS
₹10.18
No. of employees
2K
News stories
From web sources and news partners
About Anthem Biosciences Limited
CEO-
Employees2.28K
Founded2006
Headquarters-
SectorHealth care
Websiteanthembio.com
Last report
Jul 22, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹2.11 / ₹1.80
+17.22%beat
Revenue / Est. (INR)
4.18B / 4.43B
-5.60%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.50B
4.23B
6.16B
4.18B
Cost of goods sold
2.23B
1.43B
2.57B
1.46B
Cost of revenue
2.23B
1.43B
2.57B
1.46B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
677.16M
704.79M
745.64M
788.36M
Operating expense
1.42B
1.58B
1.22B
1.51B
Total operating expenses
3.66B
3.00B
3.80B
2.98B
Operating income
1.84B
1.23B
2.36B
1.21B
Other non operating income
482.29M
335.30M
-1.05B
248.87M
EBT including unusual items
2.30B
1.30B
2.78B
1.45B
EBT excluding unusual items
2.30B
1.56B
2.67B
1.45B
Income tax expense
561.74M
376.57M
881.59M
246.40M
Effective tax rate
24.47%
28.86%
31.72%
17.04%
Other operating expenses
410.47M
528.85M
79.01M
426.16M
Net income
1.73B
928.17M
1.90B
1.20B
Net profit margin
31.53%
21.93%
30.81%
28.68%
Earnings per share
-
1.96
-
2.11
Interest and investment income
-
-
792.70M
-
Interest expense
-30.31M
-3.52M
-15.47M
-8.87M
Net interest expenses
-30.31M
-3.52M
777.23M
-8.87M
Depreciation and amortization charges
334.99M
345.33M
395.91M
299.87M
EBITDA
2.14B
1.45B
2.69B
1.54B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps